These medications include GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy, Rybelsus) and liraglutide, as well as dual GIP/GLP-1 receptor agonists like tirzepatide (Mounjaro, Zepbound)
However, this reduced side effect profile reflects reduced efficacy, not superior safety or outcomes
At this stage, neither Toujeo nor GLP-1 medications are typically involved
If you have questions or concerns about taking prednisone, dont hesitate to discuss them with your healthcare provider
161 ScaffidiC.FuldaS.SrinivasanA.FriesenC.LiF.TomaselliK
For researchers interested in peptide stacking strategies , this combination represents one of the more evidence-supported pairings